Ontology highlight
ABSTRACT: Objectives
Antithrombotic therapy (ATT) prevents atherothrombotic events (AE) in patients with peripheral arterial disease (PAD). However, the benefit may be compromised by poor medication adherence (MA). Therefore, our primary objective was the proportion of patients with PAD with poor MA in literature following patient-reported, pharmacy-reported or laboratory-reported outcome measurements. Poor MA is a combined outcome of primary non-adherence (inability to initiate a prescription), secondary non-adherence (incorrect daily intake) and non-persistence (discontinuation of daily intake).Design
Systematic review based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses statement.Data sources
PubMed, EMBASE and Cochrane Library were searched from
SUBMITTER: Wegerif EC
PROVIDER: S-EPMC11877208 | biostudies-literature | 2025 Feb
REPOSITORIES: biostudies-literature